Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1

Metformin has been reported to possess antitumor activity and maintain high cytotoxic T lymphocyte (CTL) immune surveillance. However, the functions and detailed mechanisms of metformin’s role in cancer immunity are not fully understood. Here we show metformin increases CTL activity by reducing the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cell
Hlavní autoři: Cha, Jong-Ho, Yang, Wen-Hao, Xia, Weiya, Wei, Yongkun, Chan, Li-Chuan, Lim, Seung-Oe, Li, Chia-Wei, Kim, Taewan, Chang, Shih-Shin, Lee, Heng-Huan, Hsu, Jennifer L., Wang, Hung-Ling, Kuo, Chu-Wei, Chang, Wei-Chao, Hadad, Sirwan, Purdie, Colin A., McCoy, Aaron M., Cai, Shirong, Tu, Yizheng, Litton, Jennifer K., Mittendorf, Elizabeth A., Moulder, Stacy L., Symmans, William F, Thompson, Alastair M., Piwnica-Worms, Helen, Chen, Chung-Hsuan, Khoo, Kay-Hooi, Hung, Mien-Chie
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6786495/
https://ncbi.nlm.nih.gov/pubmed/30118680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2018.07.030
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky